Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
From a virtual chemical space containing more than 60 billion molecules, we precisely choose certain compounds. Our collaborator, Reaxense, aids in their synthesis and provision.
In the library, a selection of top modulators is provided, each marked with 38 ADME-Tox and 32 parameters related to physicochemical properties and drug-likeness. Also, every compound comes with its best docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
This approach involves comprehensive molecular simulations of the catalytic and allosteric binding pockets and ensemble virtual screening that accounts for their conformational flexibility. In the case of designing modulators, the structural adjustments caused by reaction intermediates are considered to improve activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P17540
UPID:
KCRS_HUMAN
Alternative names:
Basic-type mitochondrial creatine kinase; Sarcomeric mitochondrial creatine kinase
Alternative UPACC:
P17540; Q6ICS8; Q8N1E1
Background:
Creatine kinase S-type, mitochondrial, also known as basic-type mitochondrial creatine kinase or sarcomeric mitochondrial creatine kinase, plays a pivotal role in energy transduction. It catalyzes the reversible transfer of phosphate between ATP and various phosphogens, crucial for tissues with high energy demands like skeletal muscle and the heart.
Therapeutic significance:
Understanding the role of Creatine kinase S-type, mitochondrial could open doors to potential therapeutic strategies.